AV-223

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAV-223
Drug Alias NameAV-223
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsInterferon modulators
TargetsUpdating
Therapy Area/IndicationsPicornavirus infectionCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnver Bioscience Design Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnver Bioscience Design Inc
Active IndicationsN/A
Inactive IndicationsPicornavirus infectionCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A